DBPR108
DBPR108 is an orally active, dipeptide-based DPP4 inhibitor with an IC50 of 15 nM, demonstrating high selectivity as it does not inhibit DPP8 or DPP9. This compound is a valuable research tool for investigating DPP4 function in metabolic diseases, including diabetes, in both in vitro enzymatic assays and in vivo pharmacological studies.
Product Specifications
CAS Number
1186426-66-3
Product Name Alternative
Dipeptidyl Peptidase, DPP-4, DPP4, DPP, inhibit, Inhibitor, DBPR108, DBPR-108, DBPR 108
Field of Research
Protein Biochemistry
Purity
99.65% (May vary between batches)
Solubility
DMSO:≥ 25 mg/mL (77.07 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (6.17 mM)
Smiles
CC (C) (CC (=O) N1CCCC1) NCC (=O) N1C[C@@H] (F) C[C@H]1C#N
Molecular Formula
C16H25FN4O2
Molecular Weight
324.39
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
IRTAMLCD11BM170CPETR100UG 100 µg
Anti Multi-Species CD11b Flow Cytometry Monoclonal Clone M170 PE/TR 100ug
Sign In for Pricing
View Details 
K0552307 1.0 µg DNA
CYP2T3P sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)
Sign In for Pricing
View Details AAP83661-100UG 100 µg
PARPBP Peptide - C-terminal region (AAP83661)
Sign In for Pricing
View Details RC220947L3 10 µg
Cyclin M3 (CNNM3) (NM_199078) Human Tagged Lenti ORF Clone
Sign In for Pricing
View Details